Adrian Gottschalk

CIK: 0001828724

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)8 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

FHTX

Foghorn Therapeutics Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (10 total)

FHTX
Foghorn Therapeutics Inc.
Apr 10, 2026
Gift(G)
Indirect
59.2K shares-
FHTX
Foghorn Therapeutics Inc.
Apr 10, 2026
Gift(G)
Indirect
59.2K shares-
FHTX
Foghorn Therapeutics Inc.
Apr 9, 2026
Gift(G)
Indirect
47.5K shares-
FHTX
Foghorn Therapeutics Inc.
Apr 9, 2026
Gift(G)
Indirect
47.5K shares-
FHTX
Foghorn Therapeutics Inc.
Feb 5, 2026
Award(A)
Stock option (right to buy)
Direct
1.1M shares at avg. $5.23-
FHTX
Foghorn Therapeutics Inc.
Apr 25, 2025
Gift(G)
Indirect
300K shares-
FHTX
Foghorn Therapeutics Inc.
Apr 25, 2025
Gift(G)
Indirect
300K shares-
FHTX
Foghorn Therapeutics Inc.
Apr 9, 2025
Gift(G)
Indirect
197.9K shares-
FHTX
Foghorn Therapeutics Inc.
Apr 9, 2025
Gift(G)
Indirect
197.9K shares-
FHTX
Foghorn Therapeutics Inc.
Jan 22, 2025
Award(A)
Stock Option (right to buy)
Direct
400K shares at avg. $4.37-

		Type	Shares	Price		Ownership
Apr 10, 2026	FHTX Foghorn Therapeutics Inc.	Gift(G)	59,208	-	$0	Indirect
Apr 10, 2026	FHTX Foghorn Therapeutics Inc.	Gift(G)	59,208	-	$0	Indirect
Apr 9, 2026	FHTX Foghorn Therapeutics Inc.	Gift(G)	47,497	-	$0	Indirect
Apr 9, 2026	FHTX Foghorn Therapeutics Inc.	Gift(G)	47,497	-	$0	Indirect
Feb 5, 2026	FHTX Foghorn Therapeutics Inc.	Award(A) Stock option (right to buy)	1,075,000	$5.23	-	Direct
Apr 25, 2025	FHTX Foghorn Therapeutics Inc.	Gift(G)	300,000	-	-	Indirect
Apr 25, 2025	FHTX Foghorn Therapeutics Inc.	Gift(G)	300,000	-	-	Indirect
Apr 9, 2025	FHTX Foghorn Therapeutics Inc.	Gift(G)	197,906	-	-	Indirect
Apr 9, 2025	FHTX Foghorn Therapeutics Inc.	Gift(G)	197,906	-	-	Indirect
Jan 22, 2025	FHTX Foghorn Therapeutics Inc.	Award(A) Stock Option (right to buy)	400,000	$4.37	-	Direct

1-10 of 10 transactions

About GOTTSCHALK ADRIAN

GOTTSCHALK ADRIAN (SEC CIK 0001828724) files insider reports with the SEC as Chief Executive Officer of Foghorn Therapeutics Inc. (FHTX).

Signal8 holds 5 ownership filings by GOTTSCHALK ADRIAN, all Form 4s, filed between Jan 24, 2025 and Apr 13, 2026. Those filings report 10 transactions, from Jan 22, 2025 to Apr 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GOTTSCHALK ADRIAN's filings is in WATERTOWN, MA.

Recent filings by GOTTSCHALK ADRIAN

Apr 10, 2026: Gifts of FHTX shares (2 lines, Form 4, code G).
Apr 9, 2026: Gifts of FHTX shares (2 lines, Form 4, code G).
Feb 5, 2026: Grant or award of FHTX derivative securities (Form 4, code A).
Apr 25, 2025: Gifts of FHTX shares (2 lines, Form 4, code G).
Apr 9, 2025: Gifts of FHTX shares (2 lines, Form 4, code G).

Other insiders filing for Foghorn Therapeutics Inc. (FHTX)

BVF PARTNERS L P/IL, 10% Owner
Lynch Thomas J. Jr., Director
Duty Stuart, Director
Biller Scott, Director
Gallagher Neil, Director
Mendelsohn Michael, Director

How to read Form 4 transaction codes